Vivo Capital Fund VIII, L.P.

Insider profile

Vivo Capital Fund VIII, L.P.'s trades of Terns Pharmaceuticals, Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
55.23
Quantity 33,647
Value US$1,432,766
Transaction date
Proposed sale
Price
74.44
Quantity 86,872
Value US$1,167,803
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-04-03 2024-04-03 PrS Proposed sale
33,647
55.23
US$1,432,766
33,647 55.23 US$1,432,766
2024-04-01 2024-04-01 PrS Proposed sale
86,872
74.44
US$1,167,803
86,872 74.44 US$1,167,803